Clonality analysis suggests that early-onset acute lymphoblastic leukaemia is of single-cell origin and implies no major role for germ cell mutations in parents by Rinaldi, F et al.
Germ line mutations provide a recognized oncogenic pathway
for some paediatric solid tumours, notably retinoblastoma and
nephroblastoma (Narod et al, 1991). Tumours resulting from germ
line mutations have characteristic young age of onset and
propensity to multiclonal genesis (e.g. bilaterality in retinoblas-
toma) whether or not familial associations are apparent. Interest in
the possible role of leukaemogenic germ cell mutations in child-
hood leukaemia was stimulated by the ‘Gardner hypothesis’
(Gardner et at, 1990) postulating increased leukaemia risk in the
offspring of fathers receiving gonadal irradiation whilst working at
the Sellafield nuclear establishment, although this hypothesis is
not supported by additional epidemiological evidence now avail-
able (Kinlen, 1993; Little et at, 1995). More recently, Shu et al
(1994) reported a statistical association between infant leukaemia
and preconceptual exposure of fathers to diagnostic X-rays, and
postulated a role for radiation-induced germ cell mutations. The
possibility of ‘paternal preconception irradiation’ (PPI) having a
causal role in leukaemia was reviewed by the Committee on the
Medical Aspects of Radiation in the Environment (COMARE)
who concluded that ‘there is no doubt that the hypothesis of PPI
causing cancer in offspring can be sustained in principle’ although
this did not seem to be the explanation for the increased incidence
of childhood leukaemia in the vicinity of the Sellafield nuclear
Plant (COMARE, 1996). The existence of vertically transmissible
leukaemia-predisposing mutant genes has been demonstrated in
transgenic mice (Langdon et al, 1986; Heisterkamp et al, 1990;
Griffiths et al, 1992) and it has been shown that these may give rise
to independently transformed leukaemic clones (Langdon et al,
1986). In very recent experimental studies, Lord et al (1998) have
reported that contamination of male mice with the a-emitter 239Pu
results in an increased susceptibility to leukaemia induction by
methyl-nitroso-urea in first-generation offspring.
It seems possible that germ cell mutations induced by environ-
mental factors (e.g. natural background radiation or diagnostic
exposures), perhaps followed by subsequent insults, could simi-
larly contribute to the pathogenesis of leukaemias and other
neoplasms in human populations. Acute lymphoblastic leukaemia
(ALL) is rarely familial but ALL in infants (< 12 months) or very
young children (< 24 months) may be suspected as genetically
predisposed because of age of onset. Infant leukaemias have
distinctive properties: prognosis is poor for ALL (Chessels et al,
1994) and characteristic aberrations at chromosome 11q23 are
often observed, usually involving rearrangements of the MLL
gene (Piu et al, 1995; Greaves, 1996). Such rearrangements are not
heritable and have been shown to originate in utero (Ford et al,
1993; Mahmoud et al, 1995), but this does not exclude the
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Very recently, Gale et al (1997) have demonstrated by polymerase
chain reaction (PCR) methodology the presence at birth of small
numbers of leukaemic cells in neonatal ‘blood spots’ of infants
who subsequently developed clinically overt leukaemia. This
finding demonstrates the prenatal origin of these leukaemias but
does not distinguish preconceptual predisposing events from
events occurring exclusively in utero.
Here we report clonality studies which are relevant to the role of
germ line mutations in the genesis of ALL. The rationale of the
study was to seek evidence of multiclonal origin of early-onset
ALL analogous to bilateral presentations of retinoblastoma (Rb) in
which one Rb gene is mutated in the germ line, leaving the other
allele to be mutated somatically (Knudson, 1971; Narod et al,
1991). ALL is also hypothesized to result from two independent
mutations (Greaves and Chan, 1986) although the genetic targets
are yet to be identified. It is of course possible that this is an under-
estimate of mutation number, but it is plausible that only a small
number of mutations would be required for a neoplasm which
presents in early childhood. We have mathematically modelled
‘two hit’ leukaemogenesis with both mutations occurring somati-
cally, or with one transmissible via the germ line. With parameters
chosen to simulate the observed age-incidence of ALL, these
studies predict that inheritance of the first mutation would cause
multiple independent leukaemogenic transformation in the
haematopoietic cells of each individual, typically resulting in ten
or more independently arising leukaemic clones by time of diag-
nosis (Wheldon et al, 1997). Multiclonality following a predis-
posing germ cell mutation is easily understood as resulting from
the large number of somatic cells which need only acquire one
further mutation to experience malignant transformation. The
predicted number of leukaemic clones (> 10) is greater than the
number of independently occurring tumours (about 3) estimated
for familial retinoblastoma (Knudson, 1971) because the higher
incidence of ALL requires higher mutation rates to be assigned to
the two-mutation model (Wheldon et al, 1997). As in Knudson’s
model, a small proportion of genetically predisposed leukaemias
may present (by chance) as a single clone: however, the present
modelling studies (Wheldon et al, 1997) suggest that the fraction
of heritably predisposed ALL patients who would present in this
way is close to zero. Therefore, we expect multiclonality in almost
all presenting ALL cases who have inherited a first mutation
(provided of course that the two-mutation model is valid). A clin-
ical corollary of this model is that early-onset leukaemias may be
difficult to treat effectively because of repeated emergence of new
leukaemic clones.
The investigation reported here provides a test of the multiclon-
ality hypothesis and indirectly of the hypothesis that early-onset
leukaemias result from the inheritance of one of two possible
mutations.
CLONALITY ANALYSIS BY X-CHROMOSOME
INACTIVATION
We tested the multiclonality hypothesis experimentally using X-
chromosome inactivation analysis. This is based upon the polymor-
phic differentiation between maternal and paternal X-chromosomes
and the discrimination between active and inactive X-chromo-
somes, by differential methylation. The first such studies, by
Fialkow (1976), utilized the expression of a rare polymorphism at
the X-linked, glucose-6-phosphate dehydrogenase gene locus. To
improve upon the low informative rate associated with this tech-
nique, Vogelstein et al (1987) employed Southern blot analysis of
differentially methylated, X-chromosomal loci containing restric-
tion fragment length polymorphisms. However, substantial
amounts of intact DNA (5–20 mg) are required for such analyses
and sufficient quantities are not readily available from pathological
specimens. Therefore, the PCR has been applied to enhance the
sensitivity of this approach. Informative X-chromosomal regions
include sequences of the genes encoding phosphoglycerate kinase
(PGK) (Gilliland et al, 1991), androgen receptor (AR) (Allen et al,
1992) and monoamine oxidase A (MAOA) (Hendriks et al, 1992).
The associated heterozygosity rates are 32%, 90% and 75% respec-
tively. Because limited amounts of leukaemic sample material were
available, PCR methodology was used in the present study. We
based our analysis on the MAOA locus because it has a higher rate
of heterozygosity than the PGK locus and its reliability is not
limited by incomplete digestion of active alleles: a shortcoming
associated with AR-PCR (Mashal et al, 1993).
MATERIALS AND METHODS
Reagents
Taq polymerase, restriction enzymes and dNTPs were purchased
from Promega (Southampton, UK). Other reagents, unless other-
wise stated, were obtained from Sigma (Dorset, UK).
DNA samples
A total of 102 samples of bone marrow (each containing less than
5 mg of DNA) from female childhood ALL patients were received
from the Department of Haematology, Sick Children’s Hospital,
Yorkhill, Glasgow; the Department of Haematology and
Oncology, Institute of Child Health, London; and the Department
of Medicine, Section of Hematology and Oncology, University of
Chicago. DNA, purified from bone marrow aspirates of chronic
myelocytic leukaemia patients, was acquired from Ms Anne
Sproul, Haematology Department, Royal Infirmary, Glasgow.
Blood and marrow were obtained originally from patients for diag-
nostic purposes. DNA was also prepared from the peripheral blood
samples of 46 healthy, adult, female and five male volunteers.
High molecular-weight DNA was purified from the mono-
nuclear cell fractions of marrow samples as described previously
(Sambrook et al, 1989). Ethanol-precipitated DNA was rehydrated
in sterile water and DNA concentration was determined by E260
measurements and by fluorescence assay using the Hoeschst
33258 method (Cooper and Stratton, 1991).
Determination of clonality
MAOA-PCR
Individuals whose clonality status is assessable by this method are
heterozygous with respect to a GT-dinucleotide/variable number
tandem repeat (VNTR) region of the MAOA gene (Hendriks et al,
1992). All DNA samples were screened by amplification at the
MAOA locus as described below and those found to be informa-
tive were subjected to clonality determination.
The method relies upon the presence of several sites recognized
by the methylation-sensitive restriction endonuclease HpaII.
These are located 5¢ relative to a highly polymorphic region of the
MAOA gene. Because inactive X-chromosomes are extensively
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cleaved by HpaII. The undigested MAOA alleles are PCR-ampli-
fied using primers that flank the 5¢ site of differential methylation
and the 3¢ hypervariable region, which is composed of a VNTR
motif and a GT microsatellite. SacI digestion produces fragments
of 258–388 bp, depending on the number of VNTR and
dinucleotide repeats. If HpaII digestion is allowed to proceed to
completion, PCR amplification and subsequent SacI digestion
produce one allelic band from monoclonally derived cell samples,
whereas two bands of reduced intensity are generated from poly-
clonal cell populations.
Two reactions were prepared: (a) 100 ng samples of genomic
DNA were digested with 5 units of HpaII; (b) the same amount of
DNA was incubated with enzyme digestion buffer in the absence
of enzyme. All reactions were in a total volume of 10 ml and all
incubations were carried out at 37°C for 18 h. HpaII digestion was
terminated by heat inactivation at 65°C for 5 min. All of the reac-
tion mixture was included in the subsequent PCR amplification.
PCR conditions were a modification of those reported (Hendriks et
al, 1992). Briefly, amplification was performed in a total volume of
100 ml containing the following components: 1.5 mM magnesium
chloride, 50 mM potassium chloride, 10 mM Tris–HCl (pH 9.0) and
0.1% (v/v) Triton X-100. After initial denaturation at 94°C for
5 min, 35 amplification cycles were performed using a Hybaid
Omnigene thermocycler (Teddington, UK). Each cycle comprised
1 min at 94°C, 1 min at 54°C and 2 min at 70°C. The following
primers were used: 5¢-CAATAAATGTCCTACACCTT-3¢ and
5¢-ACATTCTAAACCTAATAACTC-3¢ (Oswell, Southampton,
UK). After amplification, PCR products were extracted with
phenol–chloroform, ethanol precipitated and redissolved in 10-ml
digestion buffer containing 8 units of SacI. Digestion was carried out
for 2 h at 37°C, followed by heat inactivation at 65°C for 5 min. To
facilitate allele detection, digests were electrophoresed through 4%
(w/v) fine resolution Metaphor agarose gel (FMC Bioproducts, Kent,
UK) and stained with ethidium bromide. The relative intensities of
the bands were determined using photographic negatives of the
stained gels. Densitometry was performed on a Molecular Dynamics
computing densitometer (Sevenoaks, Kent, UK) and images were
analysed using the Quantity 1P Programme (Pharmacia Herts, UK).
Southern hybridization
Clonality assessment, by the analysis of differential methylation at
the 5¢ region of the PGK locus using the BstX1 polymorphism, was
performed as described (Vogelstein et al, 1987). Briefly, 6.25 mg of
genomic DNA were digested with PstI and BstXI. After precipita-
tion and redissolution, half of the DNA was digested with HpaII and
half was left undigested. Fragments were resolved in 1.0% (w/v)
agarose gels and blotted on to Hybond N membranes (Amersham
International plc, Bucks, UK) before hybridization to a PGK probe.
This was an 800-bp BamHI/EcoRI fragment from the 5¢ end of the
PGK gene, labelled to a specific activity of 5 ´ 108 cpm mg–1.
RESULTS
To ensure a true assignment of clonality, it was essential that
HpaII digestion of active MAOA alleles, prior to amplification,
proceeded to completion. This was verified by the simultaneous
processing of male DNA, whose single active X-allele was not
detectable after HpaII digestion.
The validity of the determination of the clonal status of ALL
samples by MAOA-PCR was confirmed by comparison with
clonal assessment using Southern blot analysis of the PGK locus.
Three chronic myelocytic leukaemia DNA samples (monoclonal)
and two normal peripheral blood DNA samples (polyclonal) were
analysed by both methods. The results of the Southern blot
analysis were, in every case, in agreement with those obtained by
MAOA-PCR.
To study the clonal origin of infant ALL, we attempted to PCR
amplify at the MAOA locus, samples of mononuclear cellular
DNA from bone marrow aspirates collected at the time of disease
presentation. Of the samples from 102 female paediatric ALL
patients (age range 1 month to 13 years), 72 were heterozygous at
the MAOA polymorphic locus. This is equivalent to a heterozy-
gosity rate of 71%. The age distribution of the different categories
of ALL patients is shown in Table 1.
Using the MAOA-PCR-based clonality assessment, 66 out of 72
informative presentation ALL samples were found to be mono-
clonal. The upper allele was inactive in 29 and the lower allele was
inactive in 37. The remaining six samples yielded ambiguous
results: the allele intensity ratios in the absence of HpaII digestion
were approximately unity, whereas after HpaII digestion, preferen-
tial but incomplete loss of one allele was observed resulting in
allele intensity ratios greater than 7:1 or less than 1:5.
To determine whether alteration in clonal status occurred during
the course of the disease, another means of assessing the origin of
leukaemic clones was employed. This involved a comparison of
the allele inactivation patterns of DNA isolates from presentation
and relapse marrow. Thirteen such pairs of samples (patient ages
< 2 years) were obtained. Of these, eight were informative. In
every case, the inactive allele in presentation marrow was the same
as the inactive allele observed in material obtained at the time of
relapse.
DISCUSSION AND CONCLUSIONS
To test the possible multiclonality of early onset ALL, we studied
clonal origin by MAOA-PCR methodology. Assignment of clon-
ality was possible in samples from 27 informative early-onset
patients (0.1–2.0 years) and 39 informative, older children
(2.1–12.0 years), whereas six samples gave results which could
not be confidently evaluated. This is the largest study of clonality
by X-chromosome inactivation so far reported for childhood ALL.
All of the evaluable patient samples in both age groups were found
to be monoclonal. This demonstration of single-cell origin for
childhood ALL is in agreement with the findings of an earlier
study of eight female children, aged 2–13 years (Dow et al, 1985).
The latter determination of clonality was based upon the analysis
of X-chromosome-encoded, glucose-6-phosphate dehydrogenase
isoenzymes.
A possible difficulty with the interpretation of clonality analysis
in leukaemia is that the disease does not present with individually
distinct tumours, and a leukaemic cell population which contains
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Table 1 Age distribution and diagnosis of informative ALL patients
Age (years)
Diagnosis < 1 1–2 > 2–13 <
cALL 5 4 32
Null ALL 12 3 4
Pre B-ALL 2 0 2
T-ALL 1 0 1several distinct clones may be numerically dominated at presenta-
tion by a single clone – the earliest to arise, or possibly the most
rapidly growing – giving a spurious finding of monoclonality, if
the co-existing clones fall below the detection threshold of the
assay. It is difficult to exclude this eventuality on the basis of a
single sample for each patient. However, we had available to us 66
evaluable patients, including 20 infants, and it would be surprising
that we were unable to detect clonal co-existence in any of them if
true multiclonality were in fact a common occurrence.
An alternative strategy for detection of multiclonal leukaemogen-
esis requires the provision of sequential marrow samples from the
same patient, i.e. at first presentation and at subsequent relapse. This
provides the opportunity for ‘clone-switching’ in a multiclonal
setting – the clone present at relapse being different from that occur-
ring at first diagnosis, either because the selection of a different (pre-
existing) clone has been favoured by therapy or because a new
independent clone has arisen subsequent to therapeutic eradication
of the initial clone. We obtained presentation and relapse marrow
samples from 13 patients < 2 years in this series, eight of whom
proved to be informative. In all eight cases, the clone present at
relapse did not differ in relation to X-inactivation from the original
clone, providing no evidence of multiclonality. It is not possible to
calculate precisely the probability of this occurring by chance,
because we have no way to quantify the probability that a co-
existing minor clone would be resistant to therapy, or that the orig-
inal dominant clone had been eliminated. Suppose, however, that
the original clone were indeed eliminated, and that relapse is due to
a newly arising clone (on our mathematical model this is quite a
common event). If the newly arising clone had an equal chance of
either X-chromosome’s being inactivated, then the probability of
observing the same pattern of X-inactivation at presentation and
relapse in each of eight patients is 0.57, or 0.008. Despite the restric-
tive assumptions of the calculation, it seems unlikely that we would
have failed to observe ‘clone-switching’ in any of eight cases, if
multiclonal leukaemogenesis were usually occurring. A further area
of uncertainty concerns the mathematical model which predicts
multiclonality were a germ cell mutation to be inherited (Wheldon
et al, 1997). We have previously mentioned that more than two
leukaemogenic mutations may in fact be required, although this
does not seem plausible in the case of infant leukaemia. We should
also note that our model does not allow for the inheritance of ‘modi-
fier genes’ which alter the mutability of other genes – currently
described as ‘caretaker genes’ by Kinzler and Vogelstein (1997).
Inheritance of mutant caretaker genes could provide a general
tendency to genetic instability in offspring, without necessarily
resulting in multiclonality, but it is also unlikely that the effects of
such genes would be confined to leukaemogenesis.
Because of the reservations above, we are not entitled to
conclude that our findings categorically exclude the possibility of
multiclonal leukaemogenesis, or the role of germ cell injury.
However, we have failed to find evidence of multiclonal
leukaemogenesis in the largest study of clonality in childhood
ALL to date, despite focusing on early-onset leukaemias, and
seeking additional evidence of ‘clone-switching’ between pre-
sentation and relapse. It therefore seems unlikely (though not
impossible) that germ cell mutations, from which multiclonal
leukaemogenesis would have been expected, play a major role in
the pathogenesis of even the youngest cases of ALL.
Since it is now clear from other studies (Ford et al, 1993;
Mahmoud et al, 1995; Gale et al, 1997) that the critical leukaemo-
genic events in early-onset ALL occur prenatally, it seems
probable that these events occur exclusively in-utero. (In-utero
mutational events would not result in multiclonality unless
affecting the early embryo prior to the development of yolk-sac
haemopoesis.) Further investigation of leukaemogenic hazards to
the embryo or fetus seems warranted.
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